Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Other Accumulated Expenses (2015 - 2026)

Palatin Technologies' (PTN) quarterly Other Accumulated Expenses came in at $152746.0 in Q1 2026, up 372.62% YoY from $32319.0 in Q1 2025, and up 1823.75% on a QoQ basis from $7940.0 in Q4 2025.

Palatin Technologies (PTN) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 12 years of Other Accumulated Expenses data on file, last reported at $152746.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 372.62% year-over-year to $152746.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $152746.0 (up 372.62% YoY) and the FY2025 annual result came in at $188769.0, down 80.01% from the prior year.
  • Other Accumulated Expenses rose to $152746.0 in Q1 2026, from $7940.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $5.9 million in Q1 2022 to a low of $7940.0 in Q4 2025.
  • A 5-year average of $1.6 million and a median of $173549.0 in 2025 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2023 — Other Accumulated Expenses soared 2765.49% — and 2024, when it sank 99.62%.
  • Tracing PTN's Other Accumulated Expenses over 5 years: stood at $123122.0 in 2022, then soared by 2765.49% to $3.5 million in 2023, then slumped by 97.86% to $75403.0 in 2024, then plunged by 89.47% to $7940.0 in 2025, then jumped by 1823.75% to $152746.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $152746.0 (Q1 2026), $7940.0 (Q4 2025), and $173549.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Palatin Technologies 40.37 Mn 40.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 152,746.00
Dec 31, 2025 7,940.00
Sep 30, 2025 173,549.00
Jun 30, 2025 188,769.00
Mar 31, 2025 32,319.00
Dec 31, 2024 75,403.00
Sep 30, 2024 139,731.00
Jun 30, 2024 944,150.00
Mar 31, 2024 11,972.00
Dec 31, 2023 3.53 Mn
Sep 30, 2023 3.75 Mn
Jun 30, 2023 3.86 Mn
Mar 31, 2023 3.12 Mn
Dec 31, 2022 123,122.00
Sep 30, 2022 5.52 Mn
Jun 30, 2022 157,390.00
Mar 31, 2022 5.93 Mn
Dec 31, 2021 7.07 Mn
Sep 30, 2021 209,746.00
Jun 30, 2021 185,485.00